The physiology of vitamin D receptor activation

Contributions to Nephrology

Volumn 163, Issue , 2009, Pages 206-212

  Valdivielso, Jose M ^a  

^a HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCITRIOL RECEPTOR; CELL RECEPTOR;

ARTICLE; GENETIC TRANSCRIPTION; HUMAN; PHYSIOLOGY;

CALCITRIOL; HUMANS; RECEPTORS, CALCITRIOL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION, GENETIC;

EID: 67651235727     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000223800     Document Type: Article

References (17)

1. White C, Gardiner E, Eisman J: Tissue specific and vitamin D responsive gene expression in bone. Mol Biol Rep 1998;25:45-61.
2. Cardus A, Parisi E, Gallego C, Aldea M, Fernandez E, Valdivielso JM: 1,25-Dihydroxyvitamin D-3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney Int 2006;69:1377-1384.
3. Cardus A, Panizo S, Parisi E, Fernandez E, Valdivielso JM: Differential effects of vitamin D analogues on vascular calcification. J Bone Miner Res 2007;22:860-866.
4. Valdivielso JM, Coll B, Fernandez E: Vitamin D and the vasculature: can we teach an old drug new tricks? Expert Opin Ther Targets 2009;13:29-38.
5. Hewison M, Zehnder D, Bland R, Stewart PM: 1alpha-Hydroxylase and the action of vitamin D. J Mol Endocrinol 2000;25:141-148.
6. Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, Rosenfeld MG, Willson TM, Glass CK, Milburn MV: Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 1998;395:137-143.
7. Urnov FD, Wolffe AP: Chromatin remodeling and transcriptional activation: the cast (in order of appearance). Oncogene 2001;20:2991-3006.
8. Chiba N, Suldan Z, Freedman LP, Parvin JD: Binding of liganded vitamin D receptor to the vitamin D receptor interacting protein coactivator complex induces interaction with RNA polymerase II holoenzyme. J Biol Chem 2000;275:10719-10722.
9. Brown AJ: Mechanisms for the selective actions of vitamin D analogues. Curr Pharm Des 2000;6:701-716.
10. Brown AJ, Dusso A, Slatopolsky E: Vitamin D. Am J Physiol Renal Physiol 1999;277: F157-F175.
11. Gardezi SA, Nguyen C, Malloy PJ, Posner GH, Feldman D, Peleg S: A rationale for treatment of hereditary vitamin D-resistant rickets with analogs of 1alpha,25-dihydroxyvitamin D(3). J Biol Chem 2001;276:29148-29156.
12. 3 and its A ring-modified analogs. Mol Endocrinol 1998;12:525-535.
13. 3 analogues and their 20-epi homologues with the vitamin D receptor. J Biol Chem 1997;272:3336-3345.
14. Liu YY, Nguyen C, Ali Gardezi SA, Schnirer I, Peleg S: Differential regulation of heterodimerization by 1alpha,25-dihydroxyvitamin D(3) and its 20-epi analog. Steroids 2001;66:203-212.
15. Quack M, Carlberg C: Selective recognition of vitamin D receptor conformations mediates promoter selectivity of vitamin D analogs. Mol Pharmacol 1999;55:1077-1087.
16. Issa LL, Leong GM, Sutherland RL, Eisman JA: Vitamin D analogue-specifi c recruitment of vitamin D receptor coactivators. J Bone Miner Res 2002;17:879-890.
17. Jaaskelainen T, Ryhanen S, Mahonen A, Deluca HF, Maenpaa PH: Mechanism of action of superactive vitamin D analogs through regulated receptor degradation. J Cell Biochem 2000;76:548-558.